| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.14▲ | 3.15▼ | 3.12▲ | 3.14▲ | 2.97▲ |
| MA10 | 3.13▲ | 3.10▲ | 3.10▲ | 3.15▼ | 2.98▲ |
| MA20 | 3.14▲ | 3.10▲ | 3.14▲ | 2.95▲ | 2.63▲ |
| MA50 | 3.10▲ | 3.14▲ | 3.14▲ | 2.97▲ | 2.36▲ |
| MA100 | 3.12▲ | 3.14▲ | 3.00▲ | 2.50▲ | 2.65▲ |
| MA200 | 3.14▲ | 2.97▲ | 2.99▲ | 2.20▲ | 5.17▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.011▲ | 0.002▲ | 0.020▲ | 0.038▲ |
| RSI | 55.690▲ | 53.964▲ | 52.768▲ | 55.345▲ | 57.935▲ |
| STOCH | 50.694 | 82.222▲ | 52.438 | 71.376 | 45.628 |
| WILL %R | -50.000 | -26.667 | -33.333 | -14.179▲ | -47.965 |
| CCI | -18.301 | 85.930 | 37.710 | 45.612 | 27.668 |
| MA | $ADCT Price Crossed Above MA(7) | Set Alert |
|
Wednesday, August 27, 2025 04:28 AM
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that Ameet Mallik, Chief Executive Officer, will ...
|
|
Wednesday, August 13, 2025 05:31 AM
Q2 2025 Earnings Call Transcript August 12, 2025 ADC Therapeutics S.A. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.36. Operator: Good morning, ladies and ...
|
|
Wednesday, August 13, 2025 12:36 AM
Despite increased revenues and promising trial data, ADC Therapeutics SA (ADCT) faces challenges with rising expenses and strategic workforce reductions.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/08/25 | 3.125 | 3.145 | 3.125 | 3.145 | 2,075 |
| 26/08/25 | 3.10 | 3.19 | 3.035 | 3.17 | 692,404 |
| 25/08/25 | 3.18 | 3.22 | 3.08 | 3.09 | 306,653 |
| 22/08/25 | 3.12 | 3.235 | 3.08 | 3.18 | 1,182,650 |
| 21/08/25 | 3.08 | 3.16 | 3.045 | 3.10 | 464,529 |
| 20/08/25 | 3.09 | 3.135 | 3.01 | 3.11 | 497,976 |
| 19/08/25 | 3.24 | 3.24 | 3.02 | 3.11 | 452,523 |
| 18/08/25 | 3.13 | 3.24 | 3.12 | 3.24 | 628,433 |
| 15/08/25 | 3.21 | 3.24 | 3.095 | 3.13 | 465,240 |
| 14/08/25 | 3.07 | 3.22 | 2.98 | 3.19 | 719,694 |
|
|
||||
|
|
||||
|
|